143 related articles for article (PubMed ID: 37672060)
21. Preoperative prediction of complete resection in pancreatic cancer.
Shah D; Fisher WE; Hodges SE; Wu MF; Hilsenbeck SG; Charles Brunicardi F
J Surg Res; 2008 Jun; 147(2):216-20. PubMed ID: 18498873
[TBL] [Abstract][Full Text] [Related]
22. Surgical resectability of pancreatic adenocarcinoma: CTA.
Wong JC; Raman S
Abdom Imaging; 2010 Aug; 35(4):471-80. PubMed ID: 19468791
[TBL] [Abstract][Full Text] [Related]
23. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
[TBL] [Abstract][Full Text] [Related]
24. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.
Tian N; Wu D; Zhu L; Zeng M; Li J; Wang X
BMC Med Imaging; 2022 Jul; 22(1):116. PubMed ID: 35786426
[TBL] [Abstract][Full Text] [Related]
25. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
26. Ductal adenocarcinoma of the pancreas with intratumoral calcification.
Kim T; Murakami T; Takahashi S; Hori M; Sakon M; Nakamori S; Wakasa K; Nakamura H
Abdom Imaging; 1999; 24(6):610-3. PubMed ID: 10525818
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
28. Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: A retrospective cohort study.
Vyas SJ; Puri YS; John BJ; Yu D; Watkins J; Imber C; Fusai G; Arjun S; Sharma D; Davidson BR; Malago M; Rahman S
J Cancer Res Ther; 2016; 12(1):417-21. PubMed ID: 27072273
[TBL] [Abstract][Full Text] [Related]
29. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
Kang JS; Choi YJ; Byun Y; Han Y; Kim JH; Lee JM; Sohn HJ; Kim H; Kwon W; Jang JY
Br J Surg; 2021 Dec; 109(1):105-113. PubMed ID: 34718433
[TBL] [Abstract][Full Text] [Related]
30. [Surgical treatment of pancreatic cancer].
Bruns CJ; Jauch KW
Dtsch Med Wochenschr; 2007 Apr; 132(15):798-802. PubMed ID: 17427089
[No Abstract] [Full Text] [Related]
31. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT.
Loyer EM; David CL; Dubrow RA; Evans DB; Charnsangavej C
Abdom Imaging; 1996; 21(3):202-6. PubMed ID: 8661548
[TBL] [Abstract][Full Text] [Related]
32. [Double-spiral-CT in preoperative assessment of the resectability of pancreas carcinoma].
Stemplinger J; Lehner K; Hermann M; Roder J; Helmberger H
Rontgenpraxis; 1998; 51(4):135-40. PubMed ID: 9676140
[No Abstract] [Full Text] [Related]
33. A palpable pancreatic duct.
Hernandez JM; Brown ZJ; D'Angelica MI
Surgery; 2017 Dec; 162(6):1340-1342. PubMed ID: 28859951
[No Abstract] [Full Text] [Related]
34. Comparison of CT and angiography in assessing resectability of pancreatic carcinoma.
Jafri SZ; Aisen AM; Glazer GM; Weiss CA
AJR Am J Roentgenol; 1984 Mar; 142(3):525-9. PubMed ID: 6607638
[TBL] [Abstract][Full Text] [Related]
35. CT perfusion and diffusion-weighted MR imaging of pancreatic adenocarcinoma: can we predict tumor grade using functional parameters?
Kovač JD; Đurić-Stefanović A; Dugalić V; Lazić L; Stanisavljević D; Galun D; Mašulović D
Acta Radiol; 2019 Sep; 60(9):1065-1073. PubMed ID: 30428264
[No Abstract] [Full Text] [Related]
36. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT.
Morgan DE; Waggoner CN; Canon CL; Lockhart ME; Fineberg NS; Posey JA; Vickers SM
AJR Am J Roentgenol; 2010 Mar; 194(3):615-22. PubMed ID: 20173136
[TBL] [Abstract][Full Text] [Related]
37. Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma.
Kaneko OF; Lee DM; Wong J; Kadell BM; Reber HA; Lu DS; Raman SS
J Comput Assist Tomogr; 2010; 34(5):732-8. PubMed ID: 20861777
[TBL] [Abstract][Full Text] [Related]
38. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery.
Raptopoulos V; Steer ML; Sheiman RG; Vrachliotis TG; Gougoutas CA; Movson JS
AJR Am J Roentgenol; 1997 Apr; 168(4):971-7. PubMed ID: 9124153
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography of pancreatic adenocarcinoma: comparison of tumor size measured by dynamic computed tomography and histopathologic examination.
Furukawa H; Takayasu K; Mukai K; Inoue K; Kosuge T; Ushio K
Pancreas; 1996 Oct; 13(3):231-5. PubMed ID: 8884842
[TBL] [Abstract][Full Text] [Related]
40. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
